Albert Mu, DO
Adult Medicine · Fresno, CANPI 1205001559
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.4% of the total across 79 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 14.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,076 and has fallen 96.6% since, to $37 in 2025.
Across 79 payments — averaging $19.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$217
- AstraZeneca$179
- Astellas Pharma US Inc$168
- Amgen$147
- Johnson & Johnson$111
- AbbVie$82
- plus $614 from 23 others
What the payments were for
- Food & beverage$1,40292%
- Education$1158%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 7 | $217 |
| AstraZeneca | 10 | $179 |
| Astellas Pharma US Inc | 5 | $168 |
| Amgen(2 entities) | 8 | $147 |
| Johnson & Johnson | 7 | $111 |
| AbbVie(2 entities) | 5 | $82 |
| Boston Scientific | 4 | $71 |
| Boehringer Ingelheim | 5 | $68 |
| Pfizer | 3 | $47 |
| Novo Nordisk | 3 | $45 |
| Dermira, Inc. | 1 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $30 |
| Teva Pharmaceuticals USA, Inc. | 2 | $26 |
| Lilly USA, LLC | 2 | $25 |
| Xeris Pharmaceuticals, Inc. | 1 | $24 |
| Advanced Respiratory, Inc | 1 | $23 |
| Amarin Pharma, Inc. | 1 | $21 |
| Genentech USA, Inc. | 1 | $20 |
| Sanofi-aventis U.S. LLC | 1 | $20 |
| Inspire Medical Systems, Inc. | 1 | $20 |
| Coloplast | 1 | $18 |
| BD | 1 | $18 |
| Medtronic | 1 | $16 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $16 |
| Sanofi Pasteur Inc. | 1 | $16 |
| Hologic Sales And Service, LLC | 1 | $15 |
| Abbott | 1 | $15 |
| Radius Health, Inc. | 1 | $14 |
| Merck | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TRELEGY ELLIPTA$125
How this compares
$1,517 in reported general payments places this provider in the 80th percentile of 221 adult medicine providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 32 | $1,131 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 11 | $337 |
| Fluticasone Propionate | 30 | $260 |
| Prednisone | 22 | $36 |
Paid to pharmacies, not to this prescriber.
Other adult medicine in Fresno
- Luis MartinezFresno$2K
- Gessie LurlayFresno$1K
- Susan HutchinsonLaguna Hills$1M
- Natalia GuzmanLos Angeles$583K
- Richard FauselRancho Mirage$30K
- Benedicto EstoestaValley Springs$22K
- Antoine DipsiaW. Sacramento$21K
- Patrick WelchArroyo Grande$20K
- Craig BobsonManteca$19K
- Tin WongLos Angeles$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.